Future research should investigate the possibility of OC synergizing with established Wnt inhibitors such as LGK974 (Porcupine inhibitor), PRI-724 (β-catenin transcriptional inhibitor), or XAV939 (Tankyrase inhibitor) to enhance its therapeutic efficacy in CRC. The gene discussed is TNKS; the disease is colorectal carcinoma.